Fulgent Genetics (FLGT)
(Delayed Data from NSDQ)
$19.84 USD
-0.15 (-0.75%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $19.84 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$19.84 USD
-0.15 (-0.75%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $19.84 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
Zacks News
FULGENT GENETIC (FLGT) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
FULGENT GENETIC (FLGT) closed at $87.17 in the latest trading session, marking a -0.31% move from the prior day.
FULGENT GENETIC (FLGT) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
FULGENT GENETIC (FLGT) closed at $83.53 in the latest trading session, marking a +1.17% move from the prior day.
FULGENT GENETIC (FLGT) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, FULGENT GENETIC (FLGT) closed at $75.69, marking a +1.16% move from the previous day.
FULGENT GENETIC (FLGT) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, FULGENT GENETIC (FLGT) closed at $84, marking a +0.1% move from the previous day.
FULGENT GENETIC (FLGT) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
FULGENT GENETIC (FLGT) delivered earnings and revenue surprises of 10.02% and 13.35%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
FULGENT GENETIC (FLGT) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
FULGENT GENETIC (FLGT) closed the most recent trading day at $73.01, moving +1.61% from the previous trading session.
What's in Store for Fulgent Genetics' (FLGT) Q1 Earnings?
by Zacks Equity Research
COVID-19 testing and NGS-based testing solutions are expected to have contributed to Fulgent Genetics' (FLGT) Q1 earnings.
FULGENT GENETIC (FLGT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
FULGENT GENETIC (FLGT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FULGENT GENETIC (FLGT) Gains As Market Dips: What You Should Know
by Zacks Equity Research
FULGENT GENETIC (FLGT) closed at $87.64 in the latest trading session, marking a +0.52% move from the prior day.
FULGENT GENETIC (FLGT) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
FULGENT GENETIC (FLGT) closed at $86.78 in the latest trading session, marking a -0.99% move from the prior day.
FULGENT GENETIC (FLGT) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, FULGENT GENETIC (FLGT) closed at $88.95, marking a +1.37% move from the previous day.
FULGENT GENETIC (FLGT) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
FULGENT GENETIC (FLGT) closed at $85.24 in the latest trading session, marking a -0.42% move from the prior day.
Logitech, Harley-Davidson, Fulgent Genetics, Bio-Rad Laboratories and IDEXX Laboratories highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Logitech, Harley-Davidson, Fulgent Genetics, Bio-Rad Laboratories and IDEXX Laboratories highlighted as Zacks Bull and Bear of the Day
COVID-19 Resurgence Accelerates Diagnostic Testing: 3 Top Picks
by Urmimala Biswas
We have narrowed down our search to the following stocks, FLGT, BIO and IDXX based on a favorable Zacks Rank and strong prospects for 2021.
Is FULGENT GENETIC (FLGT) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (FLGT) Outperforming Other Medical Stocks This Year?
Has FULGENT GENETIC (FLGT) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (FLGT) Outperforming Other Medical Stocks This Year?
Zacks.com featured highlights include: Amkor Tech, Daqo New Energy Corp and Fulgent Genetics
by Zacks Equity Research
Zacks.com featured highlights include: Amkor Tech, Daqo New Energy Corp and Fulgent Genetics
Buy These 3 Stocks With Momentum Anomaly for Higher Returns
by Zacks Equity Research
Amkor Technology (AMKR), Daqo New Energy (DQ) and Fulgent Genetics (FLGT) are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.
FULGENT GENETIC (FLGT) Moves 8% Higher: Will This Strength Last?
by Zacks Equity Research
FULGENT GENETIC (FLGT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
FULGENT GENETIC (FLGT) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
FULGENT GENETIC (FLGT) delivered earnings and revenue surprises of 40.59% and 30.77%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Fulgent Genetics (FLGT) in Q4 Earnings?
by Zacks Equity Research
We expect strong demand for Fulgent Genetics' (FLGT) end-to-end tests for COVID-19 to have continued through the fourth quarter.
FULGENT GENETIC (FLGT) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
FULGENT GENETIC (FLGT) closed at $110.38 in the latest trading session, marking a +1.55% move from the prior day.
Is FULGENT GENETIC (FLGT) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (FLGT) Outperforming Other Medical Stocks This Year?
Top Ranked Momentum Stocks to Buy for February 24th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 24th
FULGENT GENETIC (FLGT) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
FULGENT GENETIC (FLGT) closed at $170.98 in the latest trading session, marking a -0.86% move from the prior day.